Could a simple injection after C-Section cut painkiller use?

NCT ID NCT06324942

Recruiting now Symptom relief Sponsor: University of Calgary Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether a surgeon-given nerve block (TAP block) can improve pain control after a cesarean section. The block uses a long-acting numbing medicine injected into the abdominal wall. Researchers want to see if it reduces the need for narcotics, helps women move sooner, and shortens hospital stays. About 80 women having planned C-sections will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine (TAP block)
What this could lead to: If effective, this simple nerve block could become a standard part of C-sections, reducing the need for strong painkillers and speeding recovery.
What could go wrong: This is a small, single-center trial, so results may not apply to all hospitals. The block may not provide meaningful pain relief for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CESAREAN SECTION COMPLICATIONS PAIN, POSTOPERATIVE

Contacts and locations

Locations

University of Calgary
RECRUITING

Calgary, Alberta, T2N 2T9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.